It can not only inhibit the proliferation of tumor cells by blocking the cell signaling pathway directly, but also inhibit the vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) to block the formation of tumor angiogenesis indirectly (11, 12). The gene discussed is KDR; the disease is neoplasm.